Therapeutic CD8+ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-08-14

DOI:

10.1073/pnas.2501037122

Affiliations:

5

Authors:

15

Go to article

Institutions	Authors	Share
University of Pennsylvania (Penn), United States of America (USA)	6.000000	0.40
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	4.000000	0.27
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA)	2.000000	0.13
University of New South Wales (UNSW Sydney), Australia	2.000000	0.13
ImmunityBio, Inc., United States of America (USA)	1.000000	0.07

Interested in Clinical Sciences?